COLUMN GROUP III, LP 4
Accession 0001209191-20-010107
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 4:21 PM ET
Size
27.7 KB
Accession
0001209191-20-010107
Insider Transaction Report
- Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying) - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying)
- Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying) - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total
- Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying) - Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying)
- Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying)
- Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying)
- Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying) - Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying)
- Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying)
- Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying)
- Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying)
- Conversion
Series B Preferred Stock
2020-02-18−2,740,043→ 0 total→ Common Stock (2,740,043 underlying) - Conversion
Series C Preferred Stock
2020-02-18−99,758→ 0 total→ Common Stock (99,758 underlying) - Conversion
Series A Preferred Stock
2020-02-18−5,137,583→ 0 total→ Common Stock (5,137,583 underlying) - Conversion
Common Stock
2020-02-18+7,977,384→ 7,977,384 total
Footnotes (9)
- [F1]The number of shares reflects a 1-for-4.8661 reverse stock split of the Issuer's common stock and preferred stock which became effective February 7, 2020. At the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into 1 share of the Issuer's common stock (on an adjusted basis, after giving effect to the 1-for-4.8661 reverse stock split) for no additional consideration. Shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock had no expiration date.
- [F2]The securities are directly held by The Column Group III, LP ("TCG III LP"), and indirectly held by The Column Group III GP, LP ("TCG III GP"), the general partner of TCG III LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. TCG III GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
- [F3]The securities are directly held by The Column Group III-A, LP ("TCG III-A LP"), and indirectly held by TCG III GP, the general partner of TCG III-A LP. The managing partners of TCG III GP are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of TCG III GP may be deemed to have voting and investment power with respect to such shares. TCG III GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
- [F4]The securities are directly held by Ponoi Capital II, LP ("Ponoi II LP"), and indirectly held by Ponoi II Management, LLC ("Ponoi II LLC"), the general partner of Ponoi II LP. The managing partners of Ponoi II LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi II LLC may be deemed to have voting and investment power with respect to such shares. Ponoi II LLC and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
- [F5]The securities are directly held by Ponoi Capital, LP ("Ponoi LP"), and indirectly held by Ponoi Management, LLC ("Ponoi LLC"), the general partner of Ponoi LP. The managing partners of Ponoi LLC are David Goeddel, Peter Svennilson and Tim Kutzkey. The managing partners of Ponoi LLC may be deemed to have voting and investment power with respect to such shares. Ponoi LLC and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
- [F6]Consists of 3,103,049 shares held directly by TCG III LP, 3,504,313 shares held directly by TCG III-A LP, 685,011 shares held directly by Ponoi LP and 685,011 shares held directly by Ponoi II LP.
- [F7]Consists of 2,412,789 shares held directly by TCG III LP and 2,724,794 shares held directly by TCG III-A LP.
- [F8]Consists of 643,410 shares held directly by TCG III LP, 726,611 shares held directly by TCG III-A LP, 685,011 shares held directly by Ponoi LP and 685,011 shares held directly by Ponoi II LP.
- [F9]Consists of 46,850 shares held directly by TCG III LP and 52,908 shares held directly by TCG III-A LP.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Related Parties
1- filerCIK 0001668159
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 4:21 PM ET
- Size
- 27.7 KB